217 related articles for article (PubMed ID: 24821377)
1. Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.
Popa MA; Wallace KJ; Brunello A; Extermann M; Balducci L
J Geriatr Oncol; 2014 Jul; 5(3):307-14. PubMed ID: 24821377
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer.
Hoemme A; Barth H; Haschke M; Krähenbühl S; Strasser F; Lehner C; von Kameke A; Wälti T; Thürlimann B; Früh M; Driessen C; Joerger M
Cancer Chemother Pharmacol; 2019 Apr; 83(4):763-774. PubMed ID: 30684020
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort.
Beinse G; Reitter D; Segaux L; Carvahlo-Verlinde M; Rousseau B; Tournigand C; Cudennec T; Laurent M; Boudou-Rouquette P; Paillaud E; Canouï-Poitrine F; Caillet P;
J Geriatr Oncol; 2020 May; 11(4):586-592. PubMed ID: 31445850
[TBL] [Abstract][Full Text] [Related]
4. Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications.
Pugh MJ; Vancott AC; Steinman MA; Mortensen EM; Amuan ME; Wang CP; Knoefel JE; Berlowitz DR
J Am Geriatr Soc; 2010 Mar; 58(3):465-71. PubMed ID: 20398114
[TBL] [Abstract][Full Text] [Related]
5. Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.
van Leeuwen RW; Swart EL; Boven E; Boom FA; Schuitenmaker MG; Hugtenburg JG
Ann Oncol; 2011 Oct; 22(10):2334-41. PubMed ID: 21343376
[TBL] [Abstract][Full Text] [Related]
6. Potential drug interactions in patients with a history of cancer.
Chen L; Cheung WY
Curr Oncol; 2014 Apr; 21(2):e212-20. PubMed ID: 24764706
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
10. Polypharmacy in elderly patients with cancer: clinical implications and management.
Lees J; Chan A
Lancet Oncol; 2011 Dec; 12(13):1249-57. PubMed ID: 21741307
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with drug interactions in elderly hospitalized in high complexity hospital.
Veloso RCSG; Figueredo TP; Barroso SCC; Nascimento MMGD; Reis AMM
Cien Saude Colet; 2019 Jan; 24(1):17-26. PubMed ID: 30698236
[TBL] [Abstract][Full Text] [Related]
12. Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice.
Escudero-Vilaplana V; Collado-Borrell R; Hoyo-Muñoz A; Gimenez-Manzorro A; Calles A; Osorio S; Herranz-Alonso A; Sanjurjo-Sáez M
Expert Opin Drug Saf; 2020 Aug; 19(8):1041-1048. PubMed ID: 32529857
[TBL] [Abstract][Full Text] [Related]
13. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of drug interactions in patients treated for a lung or digestive cancer].
Ghysel V; Tresch E; Marliot G; Nicot R; Lambert M; Carbonnelle G; Lartigau E; Lefebvre G
Bull Cancer; 2020 Nov; 107(11):1108-1117. PubMed ID: 33012503
[TBL] [Abstract][Full Text] [Related]
16. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
[TBL] [Abstract][Full Text] [Related]
17. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation.
Hanigan MH; Dela Cruz BL; Thompson DM; Farmer KC; Medina PJ
J Oncol Pharm Pract; 2008 Sep; 14(3):123-30. PubMed ID: 18719067
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of drug interactions in a pediatric intensive care unit].
Santibáñez C; Roque J; Morales G; Corrales R
Rev Chil Pediatr; 2014 Oct; 85(5):546-53. PubMed ID: 25697430
[TBL] [Abstract][Full Text] [Related]
19. Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol.
Steinmeyer Z; Gérard S; Filleron T; Lozano S; Brechemier D; Abellan Van Kan G; Mourey L; Cristol-Dalstein L; De Decker L; Rolland Y; Balardy L
BMC Cancer; 2019 Nov; 19(1):1153. PubMed ID: 31775667
[TBL] [Abstract][Full Text] [Related]
20. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.
Kalsi T; Babic-Illman G; Ross PJ; Maisey NR; Hughes S; Fields P; Martin FC; Wang Y; Harari D
Br J Cancer; 2015 Apr; 112(9):1435-44. PubMed ID: 25871332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
